Browse Prior Art Database

System for Detecting and Diagnosing Tissue Ischemic Stress

IP.com Disclosure Number: IPCOM000245554D
Publication Date: 2016-Mar-16
Document File: 5 page(s) / 133K

Publishing Venue

The IP.com Prior Art Database

Abstract

Relates to a system for detecting and diagnosing tissue ischemic stress. More specifically, but not exclusively, the disclosure relates to a system to a system for detecting and diagnosing the tissue ischemic stress by detecting biomarkers.

This text was extracted from a PDF file.
This is the abbreviated version, containing approximately 40% of the total text.

Page 01 of 5

System for Detecting and Diagnosing Tissue Ischemic Stress

    This disclosure generally relates to a system for detecting and diagnosing tissue ischemic stress. More specifically, but not exclusively, the disclosure relates to a system for detecting and diagnosing the tissue ischemic stress by detecting biomarkers.

    A healthcare facility may be equipped with a number of systems for detecting and diagnosing tissue ischemic stress. The systems may detect the tissue ischemic stress by detecting a biomarker. The tissue ischemic stress may refer to a situation in which the bodily tissue of a person is stressed. The stressing of tissues may cause contraction of blood vessels and thereby restrict blood flow. During the tissue ischemic stress, the body of the person may develop biomarkers. The biomarkers are molecular indicators of the tissue ischemic stress. The biomarkers, such as IL-1-alpha, CPK, and Lactic acid concentration, change in ratio of oxygen with respect to carbon dioxide. Carbon dioxide may be developed due to the tissue ischemic stress.

    The biomarkers may be detected by various methods known to a person ordinarily skilled in the art. The caregiver may sometimes not be near the person and thus diagnosing the situation may be delayed in those situations.

    This disclosure describes a system for detecting and diagnosing tissue ischemic stress by detecting a biomarker. The system includes a biosensor, and a diagnostic system. The biosensor may be manufactured by boiling silkworm cocoon in water to form a solution. The solution may be purified and mixed with antibodies and enzymes to form the biosensor. The biosensor is capable of detecting the biomarker even during low concentration of the biomarker. The biosensor may raise an alarming signal in a situation of the biomarker being detected and may activate the diagnostic system in the situation. The diagnostic system may reduce the tissue ischemic stress situation by immediately injecting anti-inflammatory agents in the infected tissue of a person.

    The block diagram shown in Fig.1 illustrates a system 100 for detecting and diagnosing tissue ischemic stress 105. The body of a person in certain conditions may develop tissue ischemic stress 105. Tissue ischemic stress 105 may refer to a situation

Page 1 of 5

Docket # 104


Page 02 of 5

where tissue of the person is stressed. Tissue ischemic stress 105 may lead to the contraction of blood vessels which may be harmful for the person. Tissue ischemic stress 105 may cause the body of the person to develop biomarkers 110. The biomarkers 110 are the molecular indicator of certain imbalances in the body of the person. The biomarkers 110 may be chemical biomarkers, such as IL-1-alpha, CPK, Lactic acid concentration, or other similar markers, or physical biomarkers, such as change in ratio of oxygen with respect to carbon dioxide and sweat. The biomarkers 110 may be detected by a biosensor 115 applied on the body of the person. The biosensors 115...